Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos Pathogens|March 6, 2018
TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilitiesAllison F Carey, Jeremy M Rock, Inna V Krieger, et al.Nature Communications|May 16, 2024
Mycobacterial biotin synthases require an auxiliary protein to convert dethiobiotin into biotinDi Qu, Peng Ge, Laure Botella, et al.Cell Chemical Biology|October 16, 2018
A Lysine Acetyltransferase Contributes to the Metabolic Adaptation to Hypoxia in Mycobacterium tuberculosisEmily S C Rittershaus, Seung-Hun Baek, Inna V Krieger, et al.Chemistry & Biology|December 25, 2012
Structure-guided discovery of phenyl-diketo acids as potent inhibitors of M. tuberculosis malate synthaseInna V Krieger, Joel S Freundlich, Vijay B Gawandi, et al.Nature Communications|April 23, 2022
CinA mediates multidrug tolerance in Mycobacterium tuberculosisKaj M Kreutzfeldt, Robert S Jansen, Travis E Hartman, et al.ACS Infectious Diseases|November 3, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in <i>Mycobacterium tuberculosis</i>Vinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg, et al.EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.ACS Infectious Diseases|April 5, 2024
Inhibitors of the Thioesterase Activity of <i>Mycobacterium tuberculosis</i> Pks13 Discovered Using DNA-Encoded Chemical Library ScreeningInna V Krieger, Subbarao Yalamanchili, Paige Dickson, et al.Cell Reports|November 6, 2024
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoNian E Zhou, Su Tang, Xuelin Bian, et al.Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.Pageof 2